Multiple upstream factors, including exosomal miR-21 derived from hepatocellular carcinoma cells[41] and soluble carcinoembryonic antigen released from colorectal cancer cells, sensitize the Akt pathway to activate CAFs and promote cancer progression.[42]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.